In connection with the proposed share issuance for asset acquisition and the raising of supporting funds, and in accordance with the relevant rules of the Shanghai Stock Exchange, trading in the Company's shares will be suspended from the market opening on July 16, 2026 upon the application of Tinavi Medical Technologies Co., Ltd. The expected suspension period will not exceed five trading days.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment